Baseline risk characterization of early versus later adopters of long‐acting paliperidone palmitate formulations

Early Post‐Marketing Phase Vigilance (EPPV) is a unique system that encourages reporting of serious adverse reactions for medications newly introduced to Japan. When a once‐monthly paliperidone palmitate formulation (PP1M) was introduced in Japan in 2013, EPPV detected a signal of increased mortalit...

Descripción completa

Detalles Bibliográficos
Autores principales: Fife, Daniel, Fortin, Stephen, Qiu, Hong, Yamazaki, Michiyo, Najarian, Dean, Voss, Erica A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Micro Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515715/
https://www.ncbi.nlm.nih.gov/pubmed/35650169
http://dx.doi.org/10.1002/npr2.12260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515715/
https://www.ncbi.nlm.nih.gov/pubmed/35650169
http://dx.doi.org/10.1002/npr2.12260

Ejemplares similares